It exhibits potent in vitro inhibitory activity against VEGFR-1 and VEGFR-2 tyrosine kinases by blocking VEGFR-1 signaling which inhibits pathological angiogenesis associated with cancer and tumor metastasis. The gene discussed is FLT1; the disease is cancer.